Insights On Trial Design

  1. Scout's Science-Based Targets Commitment: What Comes Next 1/14/2026

    Explore the latest Science Based Targets initiative commitment, clarifying what has been approved, what remains in progress, and the steps required before emissions reduction targets can be validated.

  2. Placebo Response In Clinical Trials: Challenges And Mitigation 10/21/2024

    Explore clinical trial strategies involving tailored, culturally sensitive mitigation that will allow you to navigate the complexity of placebo response.

  3. Market Fragmentation In Clinical Trial Recruitment Organizations 9/17/2025

    The fragmented clinical trial recruitment market presents challenges, but a strategic approach with platform-based solutions can streamline processes and accelerate research.

  4. Rethinking Effectiveness: Balancing Tradeoffs In An Era Of Disruption 11/12/2025

    In an era defined by rapid disruption and technological advancement, clinical operations leaders are under increasing pressure to enhance effectiveness while managing complex strategic trade-offs.

  5. 5 Proven Ways To Expand Clinical Trial Site Capacity 9/18/2025

    How can you turn capacity limits into enrollment momentum and ensure timelines stay on track while also expanding access to diverse patient populations?

  6. How Site And Patient Research Optimizes Clinical Trials 6/17/2024

    Signant’s patient and site research enhances digital health technology in clinical trials by optimizing usability and design. These insights drive improvements in product features, study designs, and training materials.

  7. Phase I Clinical Trial Designs: Bayesian Logistic Regression Model (BLRM) 9/25/2025

    The Bayesian Logistic Regression Model (BLRM) is redefining Phase I clinical trial design by bringing flexibility, precision, and patient-centered safety into early drug development.

  8. Enrollment And Retention: Applying Corporate Meetings Management Best Practices 12/8/2025

    Discover how a structured, scalable approach to patient support can streamline trial operations, improve retention, and elevate the clinical experience for everyone involved.

  9. The Flexibility Of Reconsent In Clinical Trials 5/9/2025

    Explore the common misconceptions surrounding reconsent, as well as the reality of its ability to be a flexible, ethics-driven communication practice grounded in respect for participant autonomy.

  10. Why Early RTSM Involvement Matters 3/25/2026

    Early stakeholder involvement helps spot protocol and logistical misalignments before they become operational issues, strengthening RTSM readiness and reducing activation delays.